300146 Byhealth Co.,Ltd
- 12.52
- +0.14+1.13%
Byhealth Co.,Ltd News
Tomson Beijian (300146): Single product adjustments are nearing completion, and the results of the reform can be expected to be realized
Huachuang Securities Downgrades Byhealth to Neutral From Add; Price Target Is 13.50 Yuan
Tomson Beijian (300146): Q3 results are under pressure, suggestions focus on adjustment progress
Tomson Beijian (300146): Increased competition and pressure on short-term inventory performance
Tomson Beijian (300146): Consolidate the advantages of scale and continue to expand product diversification
Tomson Beijian (300146): Repurchase cancellation enhances confidence and focuses on subsequent business strategy adjustments and optimization
Tomson Beijian (300146): Operating adjustments put pressure on performance
Tomson Beijian (300146): 24H1 performance is under pressure to adhere to the strategy of strong technology and strong brand
Tomson Beijian (300146) 2024 Interim Report Review: Iterative Upgrading of High-Base Core Single Products Over the Same Period
Tomson Beijian (300146): Performance fell short of expectations, observed adjustments and improvements
Tomson Beijian (300146): Short-term performance is under pressure, medium- to long-term strategic strength is sufficient
Tomson Beijian (300146): Profits are under pressure due to increased costs and wait for the pressure on the H2 base to ease
Tomson Beijian (300146): Performance under pressure under high base, waiting for demand to improve
Tomson Beijian (300146): Profits are under pressure due to declining revenue and increased investment under a high base
Guoyuan Securities released a research report on April 28 stating that it gave Tomson Beijian (300146.SZ) a purchase rating. The main reasons for the rating include: 1) revenue has declined under a high base, and investment in sales expenses has increased
Tomson Beijian (300146): Under pressure from a high base of 24Q1, the intention is to comprehensively deepen change in the long term
Tomson Beijian (300146) Comment: Under a high base, income is under pressure in the short term, concerns about the implementation of subsequent reforms are under pressure
Tomson Beijian (300146): Under the 1Q24 high base, the pressure-bearing material was low in 24 years and was highly repaired after 24 years
Tomson Beijian (300146): Basis reasons why Q1 revenue is under pressure, equity incentives promote the company's long-term development
Tomson Beijian (300146): Short-term pressure strategy with a high base focuses on the long term
Analysis
Price Target
No Data
No Data